University of South Florida/Tampa General Hospital — Tampa, Florida

University of South Florida/Tampa General Hospital is a clinical research site located in Tampa, Florida, United States 33606.

Crixeo Clinical Trials Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

University of South Florida/Tampa General Hospital has participated in 24 clinical trials with 9 currently active.

Therapeutic areas: Suspected Heparin-Induced Thrombocytopenia, Burns, Intracerebral Hemorrhage.

Sponsors: Canyon Pharmaceuticals, Inc., Noveome Biotherapeutics, formerly Stemnion, University of Minnesota.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Tampa

Browse all research sites in Florida · View every site in Tampa

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of South Florida/Tampa General Hospital?

University of South Florida/Tampa General Hospital has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of South Florida/Tampa General Hospital conducted?

University of South Florida/Tampa General Hospital has 24 clinical trials on record, with 9 currently active. Their work covers Suspected Heparin-Induced Thrombocytopenia, Burns, Intracerebral Hemorrhage.

Is University of South Florida/Tampa General Hospital accredited by Crixeo Clinical Trials?

University of South Florida/Tampa General Hospital has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of South Florida/Tampa General Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.